---
title: "Krisp Consulting Case Study: SAP Solutions for Pharmaceutical"
description: Krisp Consulting supported a global life sciences firm with assessment and strategy for SAP S/4HANA Private Cloud and SAP Finance deployment.
---

# Life Sciences

### Case Study: SAP S/4HANA Finance Implementation for a Global Pharmaceutical Company

###  Overview

Krisp Consulting was engaged by a Global Pharmaceutical Company to perform a comprehensive assessment and provide recommendations for the implementation of SAP S/4HANA and SAP Finance Systems. The primary objective was to streamline the company's finance operations by creating a unified finance system while leveraging existing operational processes and overcoming the limitations of their current landscape.

### Business Challenges

The company faced several critical challenges with their existing finance and operational systems:

- **Fragmented Systems**: Multiple finance systems were in place, each connected to various third-party systems, leading to inefficiencies and inconsistencies.
- **Data Silos**: Disparate systems for logistics, manufacturing, and distribution resulted in data silos, making it difficult to achieve a consolidated view of financial data.
- **Complex Integration**: The use of multiple third-party solutions for invoice management, banking operations, credit management, etc., complicated the integration landscape.
- **Legacy Systems**: A reliance on legacy systems that had reached their end-of-life added to the challenges, necessitating a phased approach to system sunset.

### Recommendations

Krisp Consulting recommended a strategic, phased approach to migrating to SAP S/4HANA using the Bluefield methodology. This approach was chosen to expedite the transition while minimizing business disruption. Key recommendations included:

- **Single Finance System**: Establish a single finance system that integrates seamlessly with logistics, manufacturing, and distribution systems until the legacy systems are sunsetted.
- **Centralized Finance Operations**: Implement centralized finance operations to bring a 'single source of truth' through one universal journal, ensuring consistent and accurate financial reporting.
- **Leverage Proven Processes**: Utilize existing, proven operational processes while enhancing them with new system functionalities like AVL (Accounting View of Logistics Documents) for sales.
- **Incremental Legacy System Sunset**: Adopt an incremental approach to gradually phase out legacy systems, ensuring continuity and minimizing risks.
- **Avoid Multiple Third-Party Connections**: Limit the number of third-party systems interfacing with finance operations to reduce complexity and improve integration.

### Implementation Strategy

The recommended Bluefield approach involved the following steps:

- **ECC System Copy and Upgrade**: Copy the existing ECC system and upgrade to SAP S/4HANA.
- **Central Finance Activation**: Activate Central Finance to enable centralized reporting and real-time data processing.
- **Data Migration**: 
    - Migrate finance information from Non-SAP systems to SAP S/4HANA, including Accounts Payable (AP), Accounts Receivable (AR), General Ledger (GL), Banking, Purchase Orders (POs), and Sales Orders.
    - Migrate finance information from SAP-ECC systems to SAP S/4HANA.

### Benefits

By implementing the recommended strategy, the Global Pharmaceutical Company is expected to achieve:

- **Enhanced Financial Visibility**: A unified view of financial data across all operations, leading to improved decision-making and strategic planning.
- **Operational Efficiency**: Streamlined processes and reduced reliance on third-party systems, resulting in cost savings and increased efficiency.
- **Scalability and Flexibility**: A future-ready finance system that supports growth and adapts to evolving business needs.
- **Risk Mitigation**: A phased implementation minimizes the risks associated with system transitions, ensuring business continuity.

### Conclusion

Krisp Consulting's assessment and recommendations provided a roadmap for the Global Pharmaceutical Company to transform its finance operations through the successful implementation of SAP S/4HANA. This strategic initiative is set to drive operational excellence, enhance financial transparency, and position the company for future growth.

#### NEWSLETTER

Sign up for our newsletter and stay updated with the latest news!

[mailto:info@bootstotheboardroom.com](mailto:info@bootstotheboardroom.com) <https://www.linkedin.com/company/105656215/admin/dashboard/> <https://www.facebook.com/people/BootstotheBoardroom/61574730220261/> <https://www.instagram.com/bootstotheboardroom/> <https://x.com/Vets2Execs> <https://www.youtube.com/@bootstotheboardroom>

#### QUICK LINKS

![ffBOOTS-TO-THE-BOARDROOM-LOGO_A5-(1)-(1)](https://bootstotheboardroom.com/hs-fs/hubfs/ffBOOTS-TO-THE-BOARDROOM-LOGO_A5-(1)-(1).png?width=300&height=56&name=ffBOOTS-TO-THE-BOARDROOM-LOGO_A5-(1)-(1).png "ffBOOTS-TO-THE-BOARDROOM-LOGO_A5-(1)-(1)")

[info@bootstotheboardroom.com](mailto:info@bootstotheboardroom.com)

[+1 (214) 272-2545](tel:+1%20(214)%20272-2545.)

---

© 2026 All Rights Reserved